Ok Biotech Co Ltd (TW:4155) — Market Cap & Net Worth
Market Cap & Net Worth: Ok Biotech Co Ltd (4155)
Ok Biotech Co Ltd (TW:4155) has a market capitalization of $59.00 Million (NT$1.87 Billion) as of May 4, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #21256 globally and #1291 in its home market, demonstrating a -2.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ok Biotech Co Ltd's stock price NT$13.00 by its total outstanding shares 144059164 (144.06 Million). Analyse 4155 cash flow metrics to see how efficiently the company converts income to cash.
Ok Biotech Co Ltd Market Cap History: 2015 to 2026
Ok Biotech Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $93.29 Million to $59.00 Million (-1.30% CAGR).
Ok Biotech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ok Biotech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Ok Biotech Co Ltd's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.99x
Ok Biotech Co Ltd's market cap is 0.99 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $93.29 Million | $856.55 Million | $110.97 Million | 0.11x | 0.84x |
| 2016 | $82.89 Million | $1.04 Billion | $85.20 Million | 0.08x | 0.97x |
| 2017 | $90.51 Million | $1.23 Billion | $126.81 Million | 0.07x | 0.71x |
| 2018 | $77.86 Million | $1.12 Billion | $161.36 Million | 0.07x | 0.48x |
| 2019 | $113.21 Million | $1.24 Billion | $125.76 Million | 0.09x | 0.90x |
| 2020 | $95.43 Million | $1.48 Billion | $129.73 Million | 0.06x | 0.74x |
| 2021 | $87.25 Million | $1.26 Billion | $31.42 Million | 0.07x | 2.78x |
| 2022 | $107.46 Million | $1.48 Billion | $143.46 Million | 0.07x | 0.75x |
| 2023 | $112.51 Million | $1.19 Billion | $2.95 Million | 0.09x | 38.17x |
| 2024 | $92.82 Million | $1.67 Billion | $93.97 Million | 0.06x | 0.99x |
Competitor Companies of 4155 by Market Capitalization
Companies near Ok Biotech Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Ok Biotech Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Ok Biotech Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Ok Biotech Co Ltd's market cap moved from $93.29 Million to $ 59.00 Million, with a yearly change of -1.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$59.00 Million | -10.34% |
| 2025 | NT$65.81 Million | -29.10% |
| 2024 | NT$92.82 Million | -17.51% |
| 2023 | NT$112.51 Million | +4.70% |
| 2022 | NT$107.46 Million | +23.16% |
| 2021 | NT$87.25 Million | -8.58% |
| 2020 | NT$95.43 Million | -15.71% |
| 2019 | NT$113.21 Million | +45.41% |
| 2018 | NT$77.86 Million | -13.98% |
| 2017 | NT$90.51 Million | +9.19% |
| 2016 | NT$82.89 Million | -11.14% |
| 2015 | NT$93.29 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Ok Biotech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $59.00 Million USD |
| MoneyControl | $59.00 Million USD |
| MarketWatch | $59.00 Million USD |
| marketcap.company | $59.00 Million USD |
| Reuters | $59.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ok Biotech Co Ltd
OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring systems and homecare healthcare devices in Taiwan and internationally. It also offers OTC hearing aids, multi-frequency therapy devices, and factory setup solutions. The company was founded in 2004 and is based in Hsinchu City, Taiwan.